Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 2/3 1

Status

Sponsor Class

OTHER 2 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Neoplasms 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Leukemia, Myeloid, Acute 2 Carcinoma, Hepatocellular 2 Weight Loss 1 Warts 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Pain 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oesophagogastric Cancer 1 Neoplasm Metastasis 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Leukopenia 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Insulin Resistance 1 Infertility 1 Immunotherapy Gastrict Cancer 1 Hydatidiform Mole 1 Glioma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER_GOV × Warts × Clear all

NCT05254561 2022-02-24

Triple Antigen vs Monoantigen Immunotherapy for Warts

Zagazig University

Phase 2/3 Completed

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡